Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293488
Status:
COMPLETED
Last Update Posted:
2016-06-23
First Post:
2006-02-16
Brief Title:
SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma
Sponsor:
Progen Pharmaceuticals
Organization:
Progen Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-02-16
First Submit QC Date:
February 16 2006
Study First Post Date:
2006-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-21
Last Update Post Date:
2016-06-23
Last Update Post Date Type:
ESTIMATED